Mercedes-Benz HPC North America says it will build EV charging hubs at most Buc-ee’s stores, starting with about 30 hubs by the end of 2024. Buc-ee's/Facebook

Buc-ee’s, the beloved Lake Jackson-based chain of convenience stores, has plugged into a partnership with a Mercedes-Benz business unit to install electric vehicle charging stations at Buc-ee’s locations.

Mercedes-Benz HPC North America says it will build EV charging hubs at most Buc-ee’s stores, starting with about 30 hubs by the end of 2024. Some Buc-ee’s hubs already are being set up and are scheduled to begin supplying EV power by the end of this year.

Mercedes-Benz HPC, a subsidiary of the German automaker, is developing a U.S. and Canadian network of EV charging stations. All of the stations will run solely on renewable energy.

“Buc-ee’s values people and partnerships,” Jeff Nadalo, general counsel at Buc-ee’s, says in a news release. “Our new collaboration with Mercedes-Benz HPC North America will continue our traditions of elevated customer convenience and excellent service that have won the hearts, trust, and business of millions in the South for more than 40 years.”

Buc-ee’s — hailed for its squeaky-clean restrooms, abundance of fuel pumps, and unique food — operates 34 supersized convenience stores in Texas and 12 locations in other states. Another seven locations are under construction in Texas, Colorado, Kentucky, Mississippi, and Missouri.

“Mercedes-Benz HPC North America's collaboration with Buc-ee’s represents an important moment in our pursuit of a national charging network that sets a new standard in both convenience and quality,” says Andrew Cornelia, president and CEO of Mercedes-Benz HPC.

“Within a remarkably short period,” Cornelia adds, “we’ve made significant strides towards opening several charging hubs at Buc-ee’s travel centers. Buc-ee’s strategic locations along major travel routes, combined with their commitment to clean and accessible amenities, aligns perfectly with our vision.”

In January 2023, Mercedes-Benz announced plans to install 10,000 EV chargers worldwide, including North America, Europe, and China. Mercedes-Benz drivers will be able to book a charging station from their car, but the network will be available to all motorists.

“The locations and surroundings of the Mercedes-Benz charging hubs will be carefully selected with wider customer needs in mind. Our best possible charging experience will therefore come with food outlets and restrooms situated nearby,” says Mercedes-Benz HPC.

Each hub will feature four to 12 chargers and ultimately as many as 30 chargers.

Mercedes-Benz says more than $1 billion is being invested in the North American charging network, which is set to be completed by 2029 or 2030. The cost will be split between the automaker and solar power producer MN8 Energy, a New York City-based spinoff of banking giant Goldman Sachs.

------

This article originally ran on EnergyCapital.

Matthew Brown (left) and Steve May wrote their report on Anchitheriomys buceei for Palaeontologia Electronica. Photo courtesy of UT Jackson School of Geosciences

Texas researchers name ancient beaver fossil after favorite Texas gas station

Beaver Country

The legend of a treasured gas station chain continues with a new chapter: a rediscovered beaver fossil is being named after Buc-ee’s.

The ancient animal was named Anchitheriomys buceei (A. buceei) by Steve May, a research associate at the University of Texas Jackson School of Geosciences and lead author of the Palaeontologia Electronica paper that describes the beaver.

A. buceei fossils were rediscovered by researchers in UT Austin’s collections and include fossils from six different Texas sites. May decided to name A. buceei after Buc-ee’s after spotting a “This is Beaver Country” billboard in 2020 that reminded him of the fossils he was studying at the time.

Though Buc-ee’s was founded in 1982, CEO Arch “Beaver” Alpin III said in a press release that his business’ history is longer than he thought, and that he may “need to rethink [their] beginnings.”

Occurrences of A. buceei can be found between 15 and 22 million years ago along the state’s gulf coast. At first glance, they don’t appear much different from current native Texas beavers. But according to the report’s co-author Matthew Brown, who is also the director of the Jackson School’s vertebrate paleontology collections, they are nearly 30 percent bigger than today’s beavers.

A partial skull fossil of the beaver was originally collected in 1941 by paleontologists. One of the original finders was Texas A&M University museum curator Curtis Hesse, who passed away four years later before he could name it a new species and publish his study.

More information about A. buceei can be found on UT Austin’s website.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”